Literature DB >> 10981112

Unmet needs in hypertension: challenges and opportunities.

J D Jackson1, P Merat.   

Abstract

On the verge of the new millennium, hypertension remains an area of significant unmet medical need. Although progress has been made in the awareness, treatment, and control of hypertension during the last half of the 20th century, recent trends suggest that progress has stalled. Unfavorable trends in awareness and control have been noted by researchers at the Mayo Clinic, in a community that is socioeconomically prosperous with easy access to primary and tertiary medical care. Evidence suggests that a renewed focus on systolic blood pressure and on efforts to maintain compliance will result in better outcomes in populations at risk. Hiatt and Goldman have presented the case for "making medicine more scientific"--that is, understanding how the application of medical care advances can best be applied to benefit population health status. This is the challenge that hypertension control presents in world populations. Aging societies make this challenge an urgent concern.

Entities:  

Mesh:

Year:  1999        PMID: 10981112     DOI: 10.1007/s11906-996-0021-z

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  42 in total

1.  The paradigm has shifted, to systolic blood pressure.

Authors:  H R Black
Journal:  Hypertension       Date:  1999-09       Impact factor: 10.190

2.  Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population.

Authors:  A Benetos; M Safar; A Rudnichi; H Smulyan; J L Richard; P Ducimetieère; L Guize
Journal:  Hypertension       Date:  1997-12       Impact factor: 10.190

3.  Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study.

Authors:  S S Franklin; S A Khan; N D Wong; M G Larson; D Levy
Journal:  Circulation       Date:  1999-07-27       Impact factor: 29.690

4.  Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

5.  Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. SAVE investigators. Survival and Ventricular Enlargement.

Authors:  G F Mitchell; L A Moyé; E Braunwald; J L Rouleau; V Bernstein; E M Geltman; G C Flaker; M A Pfeffer
Journal:  Circulation       Date:  1997-12-16       Impact factor: 29.690

6.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

7.  The long-term prognostic significance of repeated blood pressure measurements in the elderly: SPAA (Studio sulla Pressione Arteriosa nell'Anziano) 10-year follow-up.

Authors:  C Alli; F Avanzini; G Bettelli; F Colombo; V Torri; G Tognoni
Journal:  Arch Intern Med       Date:  1999-06-14

8.  Treatment of isolated systolic hypertension in the elderly: further evidence from the systolic hypertension in Europe (Syst-Eur) trial.

Authors:  J A Staessen; L Thijs; J Gasowski; H Cells; R H Fagard
Journal:  Am J Cardiol       Date:  1998-11-12       Impact factor: 2.778

Review 9.  Modern strategies to prevent coronary sequelae and stroke in hypertensive patients differ from the JNC V Consensus Guidelines.

Authors:  L Tobian; H R Brunner; J N Cohn; H Gavras; J H Laragh; B J Materson; M A Weber
Journal:  Am J Hypertens       Date:  1994-10       Impact factor: 2.689

10.  Blood pressure screening, management and control in England: results from the health survey for England 1994.

Authors:  H M Colhoun; W Dong; N R Poulter
Journal:  J Hypertens       Date:  1998-06       Impact factor: 4.844

View more
  2 in total

Review 1.  Pharmacoeconomic burden of undertreating hypertension.

Authors:  Luca Degli Esposti; Giorgia Valpiani
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

2.  The quality of life of patients with hypertension.

Authors:  J D Stein; G C Brown; M M Brown; S Sharma; H Hollands; H D Stein
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 May-Jun       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.